Cystic Fibrosis Foundation - Click here for homepage
 | Stay Informed  |  Volunteer  |  Clinical Trials
ABOUT CYSTIC FIBROSIS ABOUT THE CYSTIC FIBROSIS FOUNDATION LIVING WITH CYSTIC FIBROSIS TREATMENTS RESEARCH OVERVIEW GET INVOLVED!
In This Section
Message from the President
Foundation Leadership
Annual Report & Financial Statements
Publications & Videos
Press Room
2010 Press Releases
2009 Press Releases
2008 Press Releases
2007 Press Releases
2006 Press Releases
CFF In the News
News & Events
About 65 Roses
Locations
Governance & Policies
Milestones Campaign
Employment Opportunities
Contact Us
Quick Links
Find A Chapter
Great Strides
Become a Corporate Partner
Volunteer
Employment Opportunities
Become an Advocate
Find A Clinical Trial
Care Center Network
Drug Development Pipeline
CF Services Pharmacy
Make a Donation
Find a Chapter
Get Connected

 Lewis Black and others in the CF community share their dreams of a cure for CF. Click to watch.
 Lewis Black and others in the CF
 community share their dreams of
 a cure for CF.

Join us on YouTube at http://www.youtube.com/CysticFibrosisUSA Join us on YouTube





Join us on Facebook at www.facebook.com/CysticFibrosisFoundation Join us on Facebook





Follow us at twitter.com/CF_Foundation Follow us on Twitter
Display a Printer Friendly Version This Page

CF Foundation Supports President Obama’s Nomination of Francis Collins, M.D., Ph.D., as New NIH Director

July 9, 2009

(Bethesda, Md.) — The Cystic Fibrosis Foundation commends the nomination by President Obama of Francis Collins, M.D., Ph.D., as the new director of the National Institutes of Health (NIH).

“The CF Foundation is pleased that Dr. Collins, who was pivotal in the discovery of the gene responsible for cystic fibrosis, may lead the NIH during a time when the expanding role of science is being highlighted by President Obama,” said Robert J. Beall, Ph.D., president and CEO of the CF Foundation.

“By leading the world’s premier medical research agency, Dr. Collins will help broaden scientific understanding, which will ultimately further the CF Foundation’s quest for a cure, and will help the numerous other diseases NIH scientists are working to treat.”

In 1989, Collins and a team of Foundation-supported researchers made a giant leap forward when they identified the gene responsible for CF. The discovery propelled the field of CF into an era of therapeutics. Today, there are more than 30 potential drugs in the Foundation’s pipeline, several of which are aimed at addressing the genetic defect in CF.

The Foundation believes that Collins’ record of scientific achievements and his leadership of the National Human Genome Research Institute demonstrate that he is an exceptional candidate for director of the NIH.

About the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation, the leading organization in the United States devoted to curing and controlling cystic fibrosis, has invested more than $320 million in drug research with biotech companies since 1998 to develop therapies to fight CF. As a result, the Foundation has built a drug pipeline with more than 30 promising therapies in development. Virtually every approved CF therapy available today was made possible because of the support of the Foundation. Based in Bethesda, Md., the Foundation has 80 chapters and branch offices, and supports and accredits a nationwide network of 110 CF care centers that provide treatment and vital resources to patients and families.


Media Contact

  • Laurie Fink, Director of Media Relations: 301-841-2602; lfink@cff.org
Make a donation to the Cystic Fibrosis Foundation.
Sign up to get the latest news and information.
It's Time to Take GREAT STRIDES! Your steps TODAY will help find a cure for cystic fibrosis. Register for a walk near you!
Help discover and develop potential new treatments for CF by enrolling in a clinical trial. Click to learn more.
Cystic Fibrosis Services Pharmacy
The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.   The Cystic Fibrosis Foundation has a 4-star rating from Charity Navigator, America's largest independent evaluator of charities.